Evidence map›Paper›PMID 33017506›Full record

ReviewJournal of clinical hypertension (Greenwich, Conn.)2020

How to check whether a blood pressure monitor has been properly validated for accuracy.

Dean S Picone, Raj Padwal, Norm R C Campbell, Pierre Boutouyrie, Tammy M Brady, Michael Hecht Olsen, Christian Delles, Cintia Lombardi, Azra Mahmud, Yaxing Meng and 9 more

Open access · bronzeAbstract readReview
In one paragraph

Review in Journal of clinical hypertension (Greenwich, Conn.), 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 29 papers.

0numbers the graph read from it
0cells of the map it votes in
29citing papers in PubMed
6.3field-weighted citation impact, top 2% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

29 citing papers in PubMed, 52 citations in OpenAlex.

  1. Trial
  2. Trial
  3. Disparities in Blood Pressure Measurement.Current hypertension reports · 2026
    Review
  4. Article
  5. Article
  6. Article
  7. Review
  8. Review
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Review
  15. Review
  16. Review
  17. Review
  18. Moving toward improved access to medicines and health technologies for cardiovascular diseaseRevista panamericana de salud publica = Pan American journal of public health · 2023
    Article
  19. Review
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

19 authors at 13 institutions in 12 countries.

Dean S PiconeMenzies Institute for Medical Research, University of Tasmania, Hobart, Australia.ORCID 0000-0002-4760-1634
Raj PadwalDepartment of Medicine, University of Alberta, Edmonton, AB, Canada.ORCID 0000-0003-3541-2817
Norm R C CampbellDepartment of Medicine, Physiology and Pharmacology and Community Health Sciences, O'Brien Institute for Public Health and Libin Cardiovascular Institute of Alberta, University of Calgary, Calgary, AB, Canada.ORCID 0000-0002-1093-4742
Pierre BoutouyrieDepartment of Pharmacology, European Georges Pompidou Hospital, Assistance Publique Hôpitaux de Paris, Inserm UMR 970, Université de Paris, Paris, France.
Tammy M BradyDivision of Pediatric Nephrology, Johns Hopkins University School of Medicine, Baltimore, MD, USA.ORCID 0000-0002-1315-6747
Michael Hecht OlsenDepartment of Internal Medicine, Holbaek Hospital, Holbaek, Denmark.
Christian DellesInstitute of Cardiovascular and Medical Sciences, University of Glasgow, Glasgow, UK.
Cintia LombardiDepartment of Non-Communicable Diseases and Mental Health, Pan American Health Organization, Washington, DC, USA.
Azra MahmudKing Abdul Aziz Cardiac Center, King Abdul Aziz Medical City, Riyadh, Saudi Arabia.ORCID 0000-0002-1927-8139
Yaxing MengMenzies Institute for Medical Research, University of Tasmania, Hobart, Australia.
Gontse G MokwatsiHypertension in Africa Research Team (HART), North-West University, Potchefstroom, South Africa.
Pedro OrdunezDepartment of Non-Communicable Diseases and Mental Health, Pan American Health Organization, Washington, DC, USA.ORCID 0000-0002-9871-6845
Hoang T PhanMenzies Institute for Medical Research, University of Tasmania, Hobart, Australia.
Giacomo PucciUnit of Internal Medicine at Terni University Hospital, Department of Medicine, University of Perugia, Perugia, Italy.
Aletta E SchutteHypertension in Africa Research Team (HART), North-West University, Potchefstroom, South Africa.
Ki-Chul SungDivision of Cardiology, Department of Internal Medicine, Kangbuk Samsung Hospital, Sungkyunkwan University School of Medicine, Seoul, Korea.
Xin-Hua ZhangWorld Hypertension League, Beijing, China.
James E SharmanMenzies Institute for Medical Research, University of Tasmania, Hobart, Australia.
Accuracy in Measurement of Blood Pressure (AIM-BP) Collaborative
University of Tasmania · AUNorth-West University · ZAWorld Health Organization Regional Office for the Americas · USInserm · FRJohns Hopkins University · USKangbuk Samsung Hospital · KRKing Saud bin Abdulaziz University for Health Sciences · SAShanghai Institute of Hypertension · CNUniversity of Alberta · CAUniversity of Calgary · CAUniversity of Glasgow · GBUniversity of Perugia · ITUniversity of Southern Denmark · DK

Funding

British Heart Foundation RE/18/6/34217
6 · The paper itself

Abstract

Hypertension guidelines recommend that blood pressure (BP) should be measured using a monitor that has passed validation testing for accuracy. BP monitors that have not undergone rigorous validation testing can still be cleared by regulatory authorities for marketing and sale. This is the situation for most BP monitors worldwide. Thus, consumers (patients, health professionals, procurement officers, and general public) may unwittingly purchase BP monitors that are non-validated and more likely to be inaccurate. Without prior knowledge of these issues, it is extremely difficult for consumers to distinguish validated from non-validated BP monitors. For the above reasons, the aim of this paper is to provide consumers guidance on how to check whether a BP monitor has been properly validated for accuracy. The process involves making an online search of listings of BP monitors that have been assessed for validation status. Only those monitors that have been properly validated are recommended for BP measurement. There are numerous different online listings of BP monitors, several are country-specific and two are general (international) listings. Because monitors can be marketed using alternative model names in different countries, if a monitor is not found on one listing, it may be worthwhile cross-checking with a different listing. This information is widely relevant to anyone seeking to purchase a home, clinic, or ambulatory BP monitor, including individual consumers for use personally or policy makers and those procuring monitors for use in healthcare systems, and retailers looking to stock only validated BP monitors.

Indexed as

Blood Pressure MonitorsHypertensionBlood PressureBlood Pressure DeterminationBlood Pressure Monitoring, AmbulatoryHumansReproducibility of ResultsSphygmomanometersambulatory blood pressure/home blood pressure monitorblood pressure determinationdevicevalidation

Identifiers

PMID33017506
PMCPMC8030032
OpenAlexW3089392505

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.